The authors describe three cases of tamoxifen-associated steatohepatit
is, which resulted from a daily dosage of 20 mg used as the adjuvant t
reatment of breast carcinoma. Liver tests became normal after disconti
nuation of tamoxifen. (C) Journal of Hepatology.